ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

SYNH Syneos Health Inc

42.98
0.00 (0.00%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Syneos Health Inc SYNH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 42.98 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
42.98 42.98
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202408:00PRNUSMitsubishi Tanabe Pharma America Celebrates Eight-Year..
12/4/202408:00PRNUSMitsubishi Tanabe Pharma America to Showcase Breadth of..
08/4/202408:00PRNUSMitsubishi Tanabe Pharma America Receives U.S. Food and Drug..
10/10/202305:08EDGAR2Form 15-12G - Securities registration termination [Section..
03/10/202307:12EDGAR2Form 8-K - Current report
28/9/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202311:32EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/9/202309:47EDGAR2Form 8-K - Current report
28/9/202309:24GLOBESyneos Health Closes Transaction with Private Investment..
26/9/202316:41PRNUSCivitas Resources Set to Join S&P MidCap 400; Hayward..
26/9/202306:30GLOBESyneos Health Names Terttu Haring President, Clinical Sites..
26/9/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/9/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/9/202306:30GLOBESyneos Health and Oracle to Expand Relationship to..
12/9/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
06/9/202307:00EDGAR2Form 8-K - Current report
06/9/202306:54GLOBESyneos Health, Inc. and Star Parent, Inc. Announce Proposed..
06/9/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
05/9/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
22/8/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/8/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/8/202304:45PRNUSSYNH SHAREHOLDER ALERT: Jakubowitz Law Reminds Syneos..
09/8/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
04/8/202304:45PRNUSSYNH SHAREHOLDER ALERT: Jakubowitz Law Reminds Syneos..
03/8/202315:59EDGAR2Form 8-K - Current report
02/8/202307:47GLOBESyneos Health Stockholders Approve Agreement with Private..
02/8/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/7/202317:30PRNUSSYNH SHAREHOLDER ALERT: Jakubowitz Law Reminds Syneos..
26/7/202316:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/7/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202306:30GLOBESyneos Health Appoints Hillary Bochniak as Chief Human..
07/7/202316:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/6/202306:30GLOBESyneos Health and uMotif Partner to Deliver..
25/5/202306:30GLOBESyneos Health Appoints Batisha Anson to Global Head, Patient..
17/5/202306:30GLOBESyneos Health Leaders Recognized by HBA
16/5/202307:05GLOBESyneos Health Leaders Recognized as PM360 2023 ELITE Award..
10/5/202314:01PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
10/5/202306:07GLOBESyneos Health Reports First Quarter 2023 Results

Su Consulta Reciente

Delayed Upgrade Clock